Cary Street Partners Financial LLC Acquires Shares of 1,958 The Clorox Company (NYSE:CLX)

Cary Street Partners Financial LLC acquired a new stake in The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 1,958 shares of the company's stock, valued at approximately $318,000.

A number of other institutional investors have also recently bought and sold shares of CLX. Brooklyn Investment Group boosted its holdings in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the period. Redwood Park Advisors LLC bought a new stake in Clorox in the 4th quarter valued at about $26,000. Millstone Evans Group LLC bought a new stake in Clorox in the 4th quarter valued at about $31,000. Asset Planning Inc bought a new stake in Clorox in the 4th quarter valued at about $32,000. Finally, GKV Capital Management Co. Inc. bought a new stake in Clorox in the 4th quarter valued at about $32,000. Institutional investors own 78.53% of the company's stock.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the company's stock in a transaction on Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director now owns 4,000 shares of the company's stock, valued at approximately $546,280. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.57% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. UBS Group reduced their price target on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a research report on Thursday, April 17th. Evercore ISI set a $140.00 target price on Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Barclays lowered their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a report on Wednesday, May 7th. DA Davidson reduced their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Finally, Citigroup lowered their target price on Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research note on Monday, April 14th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $151.23.

Clorox Trading Down 2.0%

Shares of CLX stock traded down $2.76 during trading hours on Wednesday, hitting $133.57. 1,655,186 shares of the company's stock traded hands, compared to its average volume of 1,312,746. The stock's 50 day simple moving average is $141.91 and its 200 day simple moving average is $153.78. The stock has a market cap of $16.46 billion, a PE ratio of 36.49, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter last year, the company earned $1.71 earnings per share. The company's quarterly revenue was down 8.0% compared to the same quarter last year. On average, sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd were issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.65%. The ex-dividend date was Wednesday, April 23rd. Clorox's payout ratio is 87.61%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.